Preferred Label : tiemonium methylsulfate;
CISMeF synonym : 4-[3-hydroxy-3-phenyl-3-(2-thienyl)propyl]-4-methylmorpholinium methyl sulphate;
MeSH synonym : ottimal;
MeSH CAS label : 4-(3-hydroxy-3-phenyl-3-(2-thienyl)propyl)-4-methylmorpholinium, methyl sulfate (salt);
MeSH Related Number : 6504-57-0 (tiemonium methylsulfate);
Registry Number MeSH : 6504-57-0;
Codes EINECS : 229-386-0;
Is substance : O;
UNII : 8PYN0UZM30;
InChIKey : JPOKDEDHVLJMIJ-UHFFFAOYSA-M;
Origin ID : C020526;
UMLS CUI : C0076665;
ATC code(s)
CISMeF manual mappings
Exact mapping(s) to DCI
MeSH term(s) associated for indexing
Record concept(s)
Semantic type(s)
UMLS correspondences (same concept)
https://www.has-sante.fr/portail/jcms/c_2847889/fr/colchimax
2018
false
France
French
Acute idiopathic pericarditis (disorder)
treatment outcome
pericarditis
drug therapy, combination
anti-inflammatory agents
morpholines
drug combinations
opium
colchicine
tiemonium methylsulfate
administration, oral
insurance, health, reimbursement
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-02/visceralgine_18012012_avis_ct11281.pdf
http://www.has-sante.fr/portail/jcms/c_1198146/visceralgine
2012
France
French
administration, oral
synthetic anticholinergics, quaternary ammonium compounds
treatment outcome
administration, rectal
injections
abdominal pain
acute pain
pelvic pain
spasm
colonic diseases, functional
parasympatholytics
cholinergic antagonists
tiemonium methylsulfate
insurance, health, reimbursement
morpholines
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/display.jsp?id=c_400857
http://www.has-sante.fr/portail/jcms/c_1013248/colchimax
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-01/colchimax_-_ct9493.pdf
2010
France
French
tablets
morpholines
drug combinations
gout suppressants
opium
colchicine
tiemonium methylsulfate
preparations with no effect on uric acid metabolism
administration, oral
insurance, health, reimbursement
evaluation of the transparency committee
---